Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
Advanced search 
Year : 1995  |  Volume : 16  |  Issue : 3  |  Page : 177-182

Central nervous system toxicity of high dose cytosar(hdac) : report of 2 cases and review of literature.

Institute Rotary Cancer Hospital, New Delhi, India

Correspondence Address:
R Kamble
Institute Rotary Cancer Hospital, New Delhi, India

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

High dose cytosine arabinoside(2-3 gm/m2 12 hourly for 8-10 doses) is often used as consolidation therapy for the management of acute myeloid leukemia(AML). Cytosine arabinoside(Ara-C) in this dose, produces significant neurotoxocity and life threatening myelotoxicity. Over the last two years, 15 patients were administered Ara-C in the dose of 1.5-2 gms/m2 12 hrly x 10 doses as post remission consolidation therapy, three(20 percent) died due to septicemia, secondary to myelotoxicity; 2(including one who died: 13 percent) developed grade II to III neurotoxicity. Neurotoxic complications of high dose Ara-C are discussed in detail. Since intermediate dose Ara-C (0.5-1.0 gms/m2 12 hrly x 8-10 doses) is found to be as effective as high dose Ara-C, such dose is recommended to avoid high morbidity and mortality related to high dose Ara-C.

[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal